Chevron Corp vs Medtronic PLC — how do they compare? Chevron Corp trades at $196.19 (market cap $385.77B), while Medtronic PLC trades at $90.48 (market cap $116.07B). The key difference: Chevron Corp is far larger — about 3.3× Medtronic PLC's market cap, and Chevron Corp pays the higher dividend (3.62%). Which is the better fit depends on your goals.
| CVX | MDT | |
|---|---|---|
Market Cap | $385.77B | $116.07B |
Volume | 9,807,834 | — |
Sector | Energy | Health |
52-Week High | $211.14 | $105.35 |
52-Week Low | $146.72 | $73.75 |
Enterprise Value | $414.31B | $134.82B |
Dividend Yield | 3.62% | 3.18% |
Signals from Pluang's Aura AI — not financial advice
Chevron (CVX) trades at $196.66, up 5.41% today, reflecting strong momentum amid high oil prices. The stock shows bullish technical signals, with recent earnings beats and a consensus analyst price target of $214.25. Revenue declined to $184.43B in 2025, but net income margin held at 9.87%, with robust cash flow from operations of $33.94B. Recent news highlights strategic investments in Argentina and Greece, leveraging geopolitical tensions to boost production prospects.
Outlook is positive with oil price tailwinds and operational efficiency, but risks include volatile energy markets and debt increases. The stock offers a solid dividend yield and growth potential, supported by analyst bullishness, though investors should monitor execution on new projects and macroeconomic shifts affecting energy demand.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →